March 19, 2017

Pink Sheet

Will Physician Demand For Repatha Put Pressure on Payer Restrictions?

By Mary Jo Laffler

FOURIER outcomes data presented at the American College of Cardiology annual meeting fell short of expectations, but could increase physician demand for the PCSK9 inhibitor, making it harder for payers to say no.

read full article >